Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1345–1368 of 4,682 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: 6 Week Intervention Clear all

Conditions: Chronic Low Back Pain
Interventions: Mindfulness Based Therapy, Cognitive Behavioral Therapy; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 21 Years and older
Enrollment: 770 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 4
States / cities: Boston, Massachusetts • Hershey, Pennsylvania • Salt Lake City, Utah + 1 more

Conditions: Breast Cancer
Interventions: Pembrolizumab (K), Placebo (P), Paclitaxel (X), Doxorubicin (A), Epirubicin (E), Cyclophosphamide (C), Endocrine therapy, Radiation therapy, Surgery; Biological · Drug · Radiation + 1 more
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 1,240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2031
U.S. locations: 45
States / cities: Daphne, Alabama • Goodyear, Arizona • Tucson, Arizona + 39 more

Conditions: Generalized Anxiety Disorder, Social Phobia, Separation Anxiety Disorder
Interventions: Computerized Cognitive Behavioral Therapy, Treatment as usual; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 7 Years to 13 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 4
States / cities: Clearwater, Florida • Fort Lauderdale, Florida • Pensacola, Florida + 1 more

Conditions: Cardiovascular Disease, HIV
Interventions: Telephone, Educational pamphlets; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 40 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Cancer
Interventions: CC&S; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 25 Years and older
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Impulsivity
Interventions: Shaping Delay Tolerance; Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 3 Years to 6 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Anorexia Nervosa/Bulimia, Anorexia in Adolescence, Anorexia Nervosa, Atypical, Anorexia Nervosa, Binge Eating/Purging Type, Purging (Eating Disorders), Impulsive Behavior, Eating Disorders, Bulimia Nervosa, Eating Disorders in Adolescence
Interventions: Naltrexone Hydrochloride, Control; Drug · Other
Lead sponsor: Rosemary Claire Roden; Other
Eligibility: 13 Years to 25 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Breast Cancer, Cancer Survivor, Cognitive/Functional Effects
Interventions: computer-assisted cognitive training, cognitive intervention, mind-body intervention procedure, memory intervention, questionnaire administration; Other · Procedure
Lead sponsor: Stanford University; Other
Eligibility: 21 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: Stanford, California

Conditions: Quality of Life, Aging
Interventions: Intervention Group, Waitlist Control Group; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 65 Years to 99 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Joint Replacement, Arthropathy
Interventions: Patient-Specific Orthopedic Implant; Device
Lead sponsor: Restor3D; Industry
Eligibility: 18 Years and older
Enrollment: 2,250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Juvenile Justice Involvement, Drug Abuse
Interventions: Middle School Success Intervention (MSS); Behavioral
Lead sponsor: Oregon Social Learning Center; Other
Eligibility: 10 Years to 12 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
Interventions: Interferon gamma-1b, Donor Leukocyte Infusion (DLI); Drug · Biological
Lead sponsor: Sawa Ito, MD; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 3
States / cities: St Louis, Missouri • Pittsburgh, Pennsylvania • Seattle, Washington

Conditions: Physical Activity
Interventions: Fitbit®, Physical Therapy Rehab; Behavioral · Other
Lead sponsor: University of Delaware; Other
Eligibility: 45 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Developmental Disabilities, Weight Loss, Body Weight, Down Syndrome, Body Weight Changes, Intellectual Disability
Interventions: Enhanced Stop Light Diet (eSLD), Conventional Diet (CD), Face-to-face (FTF), Technology (TECH), iPad with FaceTime; Dietary Supplement · Behavioral · Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 13 Years to 21 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 2
States / cities: Kansas City, Kansas • Lawrence, Kansas

Conditions: Macular Edema, Branch Retinal Vein Occlusion
Interventions: Faricimab, Aflibercept, Sham Procedure; Drug · Procedure
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 553 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 39
States / cities: Phoenix, Arizona • Tucson, Arizona • Campbell, California + 36 more

Conditions: Old Age, Mobility Limitation, Debility
Interventions: Low-intensity resistance exercise training, High-Dose Remote ischemic conditioning (RIC), Low-Dose Remote ischemic conditioning (RIC); Other
Lead sponsor: Duke University; Other
Eligibility: 65 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Pain
Interventions: Group Acupuncture Intervention; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Mebane, North Carolina

Conditions: Tinnitus
Interventions: Tele-PTM, Wait List Control; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Somatostatin Receptor Positive, NETs, Lymphoma, Solid Tumor, CNS Tumors, Rhabdomyosarcoma, Peripheral Primitive Neuroectodermal Tumor, GIST
Interventions: Lutetium Lu 177-Edotreotide, Amino Acid Solution; Drug · Other
Lead sponsor: ITM Solucin GmbH; Industry
Eligibility: 24 Months to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2034
U.S. locations: 5
States / cities: Palo Alto, California • San Francisco, California • Cincinnati, Ohio + 2 more

Conditions: Cognitive Decline, Age-Related Memory Disorders, Postoperative Complications, Age-Related Atrophy, Postoperative Cognitive Dysfunction
Interventions: Exercise Intervention; Other
Lead sponsor: Duke University; Other
Eligibility: 60 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Metastatic Breast Cancer, Metastatic Breast Cancer (MBC), Metastatic Breastcancer
Interventions: Core Intervention, EHR Integration (On v. Off), Weekly Coaching, Social+ (on v. off), Static Goal Setting, Bi-Weekly Coaching, Highly Tailored Goal Setting; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colorectal Cancer, Ovarian Cancer, Appendiceal Cancer
Interventions: ONCOS-102, Durvalumab, Cyclophosphamide; Biological · Drug
Lead sponsor: Ludwig Institute for Cancer Research; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 6
States / cities: San Diego, California • Miami, Florida • Buffalo, New York + 3 more

Conditions: Distress, Emotional, Depression, Anxiety, Fatigue, Pain, Insomnia
Interventions: Individualized Evidence-Based Therapy in Cancer (Patients and Caregivers), Training in Individualized Evidence-Based Therapy in Cancer (Therapists); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: PreDiabetes, Obesity, Insulin Resistance
Interventions: Abbott Freestyle Libre 2, Standard physical activity and nutritional counseling for prediabetes management; Device · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 11 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Strategies to Assist With Management of Pain

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers

Case Managers for CVD Risk Reduction in HIV Clinic

A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2

Shaping Tolerance for Delayed Rewards

Oral Naltrexone In Pediatric Eating Disorders

Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

Older Veterans EmpoweRed To Use Regular Exercise (OVERTURE) II

The restor3d Outcomes Registry

Prevention Program for Problem Behaviors in Girls in Foster Care

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

A Novel Physical Therapy Administered Physical Activity Intervention After TKR: A Pilot Study

Weight Management for Adolescents With IDD

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

RIC (Remote Ischemic Conditioning) in Older Individuals

Group Acupuncture for Pain

Telephone Tinnitus Education for Patients With Traumatic Brain Injury (TBI)

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Prehabilitation Exercise Plus Perioperative Optimization of Senior Health

Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients

A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

Training in Evidence-based Treatments in Psycho-Oncology

Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes